IARC classified aspartame as possibly carcinogenic to humans (Group 2B) on the basis of limited evidence for cancer in humans (specifically, for hepatocellular carcinoma, which is a type of liver cancer).
In July 2023 the WHO's cancer agency (IARC) classified aspartame as Group 2B, 'possibly carcinogenic to humans,' citing limited evidence for liver cancer (hepatocellular carcinoma).
Exhibit 02ReassuranceInformational
JECFA concluded that the data evaluated indicated no sufficient reason to change the previously established acceptable daily intake (ADI) of 0-40 mg/kg body weight for aspartame.
The WHO/FAO Joint Expert Committee on Food Additives (JECFA) reaffirmed aspartame's acceptable daily intake of 0-40 mg/kg body weight in July 2023, finding it safe to consume within that limit.